​

Nautilus Biotechnolgy (NAUT) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

NAUT Stock Forecast

Nautilus Biotechnolgy (NAUT) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $2.50, with a high of $2.50 and a low of $2.50. This represents a 44.51% increase from the last price of $1.73.

High: $2.5 Avg: $2.5 Low: $2.5 Last Closed Price: $1.73

NAUT Stock Rating

Nautilus Biotechnolgy stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (60.00%), 1 Hold (20.00%), 1 Sell (20.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 1 1 3 Strong Sell Sell Hold Buy Strong Buy

NAUT Price Target Upside V Benchmarks

TypeNameUpside
StockNautilus Biotechnolgy44.51%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.73$1.73$1.73
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26-2---2
Jun, 26-2---2
May, 26-2---2
Apr, 26-2---2
Mar, 26-2---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 28, 2025Guggenheim$2.50$1.3092.31%44.51%
Jun 27, 2024Subbu NambiGuggenheim$6.00$2.29162.01%246.82%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 27, 2024GuggenheimBuyinitialise
Jun 03, 2024JefferiesHolddowngrade
Apr 26, 2022Zacks Investment ResearchSelldowngrade

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.51$-0.56$-0.47---
Avg Forecast$-0.56$-0.23$-0.76$-0.62$-0.74$-0.72
High Forecast$-0.53$0.14$-0.73$0.14$0.17$0.17
Low Forecast$-0.58$-0.59$-0.78$-1.39$-1.65$-1.61
Surprise %-8.93%143.48%-38.16%---

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast-$122.60K$3.51M$26.16M$29.00M$65.50M
High Forecast-$238.57K$6.82M$50.91M$56.43M$127.46M
Low Forecast-$6.63K$189.57K$1.41M$1.57M$3.54M
Surprise %------

Net Income Forecast

$-250M $-190M $-130M $-70M $-10M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-63.67M$-70.78M$-59.00M---
Avg Forecast$-69.05M$-70.21M$-94.37M$-101.30M$-107.90M$-89.94M
High Forecast$-66.10M$17.21M$-91.59M$17.83M$21.24M$20.66M
Low Forecast$-72.00M$-73.64M$-97.14M$-173.03M$-206.12M$-200.55M
Surprise %-7.79%0.81%-37.48%---

NAUT Forecast FAQ

Is Nautilus Biotechnolgy stock a buy?

Nautilus Biotechnolgy stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Nautilus Biotechnolgy is a favorable investment for most analysts.

What is Nautilus Biotechnolgy's price target?

Nautilus Biotechnolgy's price target, set by 5 Wall Street analysts, averages $2.5 over the next 12 months. The price target range spans from $2.5 at the low end to $2.5 at the high end, suggesting a potential 44.51% change from the previous closing price of $1.73.

How does Nautilus Biotechnolgy stock forecast compare to its benchmarks?

Nautilus Biotechnolgy's stock forecast shows a 44.51% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Nautilus Biotechnolgy over the past three months?

  • July 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Nautilus Biotechnolgy’s EPS forecast?

Nautilus Biotechnolgy's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.62, marking a 31.91% increase from the reported $-0.47 in 2025. Estimates for the following years are $-0.74 in 2027, and $-0.72 in 2028.

What is Nautilus Biotechnolgy’s revenue forecast?

Nautilus Biotechnolgy's average annual revenue forecast for its fiscal year ending in December 2026 is $26.16M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $29M, and $65.5M for 2028.

What is Nautilus Biotechnolgy’s net income forecast?

Nautilus Biotechnolgy's net income forecast for the fiscal year ending in December 2026 stands at $-101M, representing an 71.69% increase from the reported $-59.001M in 2025. Projections indicate $-108M in 2027, and $-89.942M in 2028.